Think of Enterprise Value as the theoretical takeover price. It is more comprehensive than market capitalization (Market Cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash, cash equivalents, and marketable securities.
EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, Aurora Cannabis's Enterprise Value is $111.5 Mil.
Aurora Cannabis's EBIT for the trailing twelve months (TTM) ended in Mar. 2026 was $-39.7 Mil. Therefore, Aurora Cannabis's EV-to-EBIT ratio for today is -2.81.
EV-to-EBITDA is calculated as Enterprise Value divided by its EBITDA. As of today, Aurora Cannabis's Enterprise Value is $111.5 Mil.
Aurora Cannabis's EBITDA for the trailing twelve months (TTM) ended in Mar. 2026 was $-28.5 Mil. Therefore, Aurora Cannabis's EV-to-EBITDA ratio for today is -3.91.
EV-to-Revenue is calculated as Enterprise Value divided by its Revenue. As of today, Aurora Cannabis's Enterprise Value is $111.5 Mil.
Aurora Cannabis's Revenue for the trailing twelve months (TTM) ended in Mar. 2026 was $233.0 Mil. Therefore, Aurora Cannabis's EV-to-Revenue ratio for today is 0.48.
EV-to-FCF is calculated as Enterprise Value divided by its Free Cash Flow. As of today, Aurora Cannabis's Enterprise Value is $111.5 Mil.
Aurora Cannabis's Free Cash Flow for the trailing twelve months (TTM) ended in Mar. 2026 was $-26.0 Mil. Therefore, Aurora Cannabis's EV-to-FCF ratio for today is -4.28.
*** Please note that the current Enterprise Value is calculated using the current market capitalization and the most recently available financial data. If key financial fields—Long-Term Debt & Capital Lease Obligation and Short-Term Debt & Capital Lease Obligation—are recorded as null in the latest reporting period, our data vendor will default to using data from the prior period with valid entries.
Aurora Cannabis (NAS:ACB) Enterprise Value Explanation
When an investor buy a company, the investor needs to pay not only the common shares, he/she also needs to pay the shareholders of Preferred Stocks. He also assumes the debt of the company, and receives the cash on the company's balance sheet.
If a company has more cash than debt, the investor actually pays less than the Market Cap because he immediately owns the cash once the transaction goes through.
The market value of Preferred Stock needs to be added to the market value of common stocks in the calculation of Enterprise Value.
For the companies with the same Market Cap, the smaller the Enterprise Value is, the cheaper the company is.
Enterprise Value can be negative when the company's net cash is more than its Market Cap. In this case the investor is basically getting the company for free and get paid for that.
1. EV-to-EBIT is calculated as Enterprise Value divided by its EBIT.
Aurora Cannabis's current Enterprise Value is $111.5 Mil.
Aurora Cannabis's EBIT for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $-39.7 Mil.
2. EV-to-EBITDA is calculated as Enterprise Value divided by its EBITDA.
Aurora Cannabis's current Enterprise Value is $111.5 Mil.
Aurora Cannabis's EBITDA for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $-28.5 Mil.
Aurora Cannabis's current Enterprise Value is $111.5 Mil.
Aurora Cannabis's Revenue for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $233.0 Mil.
Aurora Cannabis's current Enterprise Value is $111.5 Mil.
Aurora Cannabis's Cash Flow from Operations for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $-9.6 Mil.
Aurora Cannabis's current Enterprise Value is $111.5 Mil.
Aurora Cannabis's Free Cash Flow for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $-26.0 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Aurora Cannabis Enterprise Value Related Terms
Aurora Cannabis Enterprise Value Historical Data
* Premium members only.
The historical data trend for Aurora Cannabis's Enterprise Value can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Drug Manufacturers - Specialty & Generic subindustry, Aurora Cannabis's Enterprise Value, along with its competitors' market caps and Enterprise Value data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Aurora Cannabis Enterprise Value vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Aurora Cannabis's Enterprise Value distribution charts can be found below:
* The bar in red indicates where Aurora Cannabis's Enterprise Value falls into.
Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash, cash equivalents, and marketable securities.
Aurora Cannabis's Enterprise Value for the fiscal year that ended in Mar. 2026 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Aurora Cannabis (ACB) has a Enterprise Value of $111.5 Mil as of Jun. 25, 2026. Enterprise value equals the sum of market cap, debt and preferred shares less cash and equivalents. View historical data on Aurora Cannabis and its competitors.
Is Aurora Cannabis' Enterprise Value too high?
Aurora Cannabis' current Enterprise Value is $111.5 Mil. Overall, Aurora Cannabis has a GF Score™ of 63/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Aurora Cannabis' Enterprise Value compare to ZTS?
Aurora Cannabis' Enterprise Value of $111.5 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Enterprise Value for a Drug Manufacturers company?
A good Enterprise Value depends on the Drug Manufacturers industry context. However, Enterprise Value should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Enterprise Value mean?
A high Enterprise Value can signal that a stock is expensive relative to its fundamentals. Enterprise value equals the sum of market cap, debt and preferred shares less cash and equivalents. View historical data on Aurora Cannabis and its competitors. Aurora Cannabis's current Enterprise Value is $111.5 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Aurora Cannabis stock overvalued right now?
Based on GuruFocus' analysis, Aurora Cannabis (ACB) is currently considered Possible Value Trap. The stock's GF Value™ is $4.18, compared to a current price of $2.83 — trading 32.3% below its estimated fair value. The current Enterprise Value is $111.5 Mil. Aurora Cannabis' overall GF Score™ is 63/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Enterprise Value calculated?
Enterprise Value is calculated from a company's financial statements. For Aurora Cannabis (ACB), the current Enterprise Value is $111.5 Mil as of Jun. 25, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Aurora Cannabis (ACB) Overvalued in 2026?
Based on GuruFocus' analysis, Aurora Cannabis stock appears to be undervalued.
The current stock price of $2.83 is trading 32.3% below its estimated GF Value™ of $4.18.
GuruFocus considers Aurora Cannabis to be Possible Value Trap.
Key valuation signals for ACB:
Enterprise Value: $111.5 Mil
GF Value™: $4.18 vs. price of $2.83 (32.3% below fair value)
No single metric tells the full story. See the ACB stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Aurora Cannabis Inc is focused on the production, distribution, and sale of cannabis products in Canada and internationally. The Company conducts the production, distribution, and sale of medical cannabis products and, on a very limited basis, consumer cannabis products in Canada pursuant to the Cannabis Act; the production and distribution of wholesale medical cannabis in the European Union pursuant to the German Medicinal Products Act and German Narcotic Drugs Act; and the distribution of wholesale medical cannabis in various international markets, including Australia and New Zealand. Its segments are Canadian Cannabis CGU, European Cannabis CGU, Australia Cannabis CGU, and New Zealand Cannabis CGU, with Canada generating majority revenue.
63GF Score
Get the complete analysis for ACB
Enterprise Value is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ACB has been successfully added to your 
